Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 6, 2010, Pages 791-794

  Galbiati, Silvia ^a   Causarano, Vincenza ^a   Pinzani, Pamela ^b   Francesca, Salvianti ^b   Orlando, Claudio ^b   Smid, Maddalena ^a   Pasi, Federica ^a   Castiglioni, Maria T ^a   Cavoretto, Paolo ^a   Rovere Querini, Patrizia ^a   Pedroni, Silvia ^a,f   Calza, Stefano ^c   Ferrari, Maurizio ^a,d,e   Cremonesi, Laura ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e Diagnostica e Ricerca San Raffaele   (Italy)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Fetal growth restriction; Plasma markers; Preeclampsia

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DNA; MESSENGER RNA; PENTRAXIN 3;

ARTICLE; BLOOD LEVEL; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; PREDICTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORTICOTROPIN-RELEASING HORMONE; DNA; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER; SERUM AMYLOID P-COMPONENT;

EID: 77953192532     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.160     Document Type: Article

References (15)

1. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592-1594
2. Cetin I, Alvino G. Intrauterine growth restriction: implications for placental metabolism and transport. A review. Placenta 2009;30:77-82.
3. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487
4. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem 2000;46:1832-1834
5. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001;47:137-139
6. Smid M, Galbiati S, Lojacono A, Valsecchi L, Platto C, Cavoretto P, et al. Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies. Prenat Diagn 2006;26:785-790
7. Caramelli E, Rizzo N, Concu M, Simonazzi G, Carinci P, Bondavalli C, et al. Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction - a pilot study. Prenat Diagn 2003;23:367-371
8. Tsui DW, Chan KC, Chim SS, Chan LW, Leung TY, Lau TK, et al. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn 2007;27:1212-1218
9. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52:2211-2218
10. Ng EK, Leung TN, Tsui NB, Lau TK, Panesar NS, Chiu RW, et al. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem 2003;49:727-731
11. Rovere-Querini P, Antonacci S, Dell'Antonio G, Angeli A, Almirante G, Cin ED, et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol 2006;108:148-155
12. Cetin I, Cozzi V, Papageorghiou AT, Maina V, Montanelli A, Garlanda C, et al. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction. Acta Obstet Gynecol Scand 2009;88:846-849
13. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611-622
14. Hollander M, Wolfe DA. Nonparametric statistical methods, 2nd ed. New York: John Wiley & Sons, 1999.
15. Westfall PH, Young SS. Resampling-based multiple testing, 1st ed. New York: John Wiley & Sons, 1993.